CLINICAL TRIALS PROFILE FOR DIFAMILAST
✉ Email this page to a colleague
All Clinical Trials for DIFAMILAST
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT05372653 ↗ | A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis | Recruiting | Otsuka Pharmaceutical Co., Ltd. | Phase 3 | 2022-05-01 | To investigate the efficacy of 0.3% OPA-15406 ointment when administered twice daily for 4 weeks in infants younger than 2 years of age with Atopic Dermatitis |
| NCT05571943 ↗ | A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis | Recruiting | Acrotech Biopharma Inc. | Phase 3 | 2022-09-15 | This is a Phase 3, open-label study to evaluate the long-term safety of difamilast ointment 1% in subjects ≥2 years of age with mild to moderate AD. The study will also evaluate the long-term efficacy of difamilast ointment 1%, including durability of response. |
| NCT05608343 ↗ | A Phase 3, Randomized, Double-Blind Study to Assess the Efficacy of Difamilast Ointment in Mild to Moderate AD | Recruiting | Acrotech Biopharma Inc. | Phase 3 | 2022-10-01 | This is a Phase 3 Double Blind multi-center study conducted at 40 US investigational sites to assess the efficacy and safety of Difamilast Ointment 1% in subjects ≥2 years of age with mild to moderate atopic dermatitis. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DIFAMILAST
Condition Name
Clinical Trial Locations for DIFAMILAST
Trials by Country
Clinical Trial Progress for DIFAMILAST
Clinical Trial Phase
Clinical Trial Sponsors for DIFAMILAST
Sponsor Name
